Latest filing published 22 Nov 2023 for Annovis Bio, Inc., €4,586.
Insider track record
Henry Hagopian III: trading record in brief
Henry Hagopian III discloses dealings in 2 companies, chiefly Annovis Bio, Inc. and Organogenesis Holdings Inc. Between 13 January 2021 and 20 November 2023, the trades on record add up to 4 filings.
The filings describe grants, exercises and other transfers rather than trades on the open market. Grants and option exercises follow pay plans set in advance, so they reveal less about an insider's own view than a purchase made with personal money.
The latest filing, published on 22 November 2023, reports a share grant of €4,586 in Annovis Bio, Inc. Typically, a trade is published a median of 2 days after it takes place. The legal deadline for a Form 4 is two business days after the transaction. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Henry Hagopian III
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 820 shares@ US$6.1022.1% of flowCommon StockSEC:0001104659-23-120760:0
- 824 shares@ US$6.0722.1% of flowCommon StockSEC:0001104659-23-120301:0
- 1,000 shares@ US$12.6155.7% of flowCommon StockSEC:0001104659-23-044206:0
- 10,700 shares0Class A Common StockSEC:0001661181-21-000003:0
4 of 4 declarations
